What Eton Pharmaceuticals, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 16 | 31 |
| Total trades | 25 | 59 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 182,077 | 619,526 |
| Disposed | 263,221 | 560,094 |
| Net activity | −81,144 | +59,432 |
Common stock only — 7 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Erdogan-Trinkaus Ipek | Chief Commercial Officer | Nov 10 | Open-market sale · S | −1,160 | $67.88 | −$78.7K | 4,081 |
| Erdogan-Trinkaus Ipek | Chief Commercial Officer | Nov 10 | Open-market sale · S | −2,340 | $67.18 | −$157K | 5,241 |
| Erdogan-Trinkaus Ipek | Chief Commercial Officer | Nov 10 | Exercise / conversion · M | +3,500 | $15.47 | +$54.1K | 7,581 |
| Casamento Charles J | Director | Nov 10 | Open-market sale · S | −2,903 | $67.87 | −$197K | 0 |
| Casamento Charles J | Director | Nov 10 | Open-market sale · S | −33,956 | $67.11 | −$2.28M | 2,903 |
| Casamento Charles J | Director | Nov 10 | Open-market sale · S | −22,601 | $66.26 | −$1.5M | 36,859 |
| Casamento Charles J | Director | Nov 10 | Open-market sale · S | −14,715 | $65.32 | −$961K | 59,460 |
| Casamento Charles J | Director | Nov 10 | Open-market sale · S | −6,380 | $64.33 | −$410K | 74,175 |
| Casamento Charles J | Director | Nov 10 | Exercise / conversion · M | +21,000 | $3.78 | +$79.4K | 80,555 |
| Casamento Charles J | Director | Nov 10 | Exercise / conversion · M | +19,655 | $8.61 | +$169K | 59,555 |
| Casamento Charles J | Director | Nov 10 | Exercise / conversion · M | +27,400 | $3.58 | +$98.1K | 39,900 |
| Casamento Charles J | Director | Nov 10 | Exercise / conversion · M | +12,500 | $7.31 | +$91.4K | 12,500 |
| Krempa David | Chief Business Officer | Oct 06 | Open-market sale · S | −4,166 | $55.07 | −$229K | 43,381 |
| Krempa David | Chief Business Officer | Oct 02 | Exercise / conversion · M | +10,522 | — | — | 47,547 |
| Maier Paul V | Director | Aug 28 | Exercise / conversion · M | +12,500 | $7.31 | +$91.4K | 72,245 |
| Maier Paul V | Director | Aug 28 | Open-market sale · S | −128 | $61.77 | −$7.91K | 59,745 |
| Maier Paul V | Director | Aug 28 | Open-market sale · S | −13,485 | $60.21 | −$812K | 59,873 |
| Maier Paul V | Director | Aug 28 | Open-market sale · S | −36,387 | $58.64 | −$2.13M | 73,358 |
| Maier Paul V | Director | Aug 28 | Exercise / conversion · M | +50,000 | $3.78 | +$189K | 109,745 |
| Krempa David | Chief Business Officer | Aug 24 | Open-market sale · S | −25,000 | $65.07 | −$1.63M | 37,025 |
Loading...